On Wednesday shares of CBS Corporation (NYSE:CBS) closed at $59.62. Company’s sales growth for last 5 years was 1.20% and EPS growth for next 5 years is recorded as 17.38%. On March 26, The CBS Corporation (NYSE:CBS Television Network is the 2015 TV Network Brand of the Year in the 2015 Harris Poll EquiTrend® study, the Harris Poll’s annual study of brand equity.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) in last trading activity moved up 1.93% to close at $63.76. Company weekly performance is 5.67% while its quarterly performance stands at 17.29%. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is -11.17% away from its 52 week high. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) announced the launch of Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated for use in the treatment of various arrhythmias. The overall US market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 million in 2014, per IMS Health.
On last trading day Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) moved up 5.04% to close at $3.75. Its volatility for the week is 6.48% while volatility for the month is 7.63%. RIGL’s sales growth for past 5 years was 59.70% and its EPS growth for past 5 years was 17.60%. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) monthly performance is 32.98%. Jefferies assumes coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with a Buy rating and a price target of $10.00, citing favorable risk/reward into fostamatinib Ph3 data.
Expeditors International of Washington Inc. (NASDAQ:EXPD) has 0.70% insider ownership while its institutional ownership stands at 89.60%. In last trading activity company’s stock closed at $47.86. Expeditors International of Washington, Inc. (NASDAQ:EXPD), announced that R. Jordan Gates, President and Chief Operating Officer, has informed the Company of his desire to retire in 2015 and, accordingly, that he will not stand for re-election to the Board of Directors at the next Annual Meeting of Shareholders on May 21, 2015. The Company expects to announce Mr. Gates’ retirement date upon the naming of his replacement and completion of a transition plan, which is expected to be finalized later this year.
On last trading day IRIDEX Corporation (NASDAQ:IRIX) moved down -2.34% to close at $10.43. Its volatility for the week is 3.66% while volatility for the month is 5.99%. IRIX’s sales growth for past 5 years was 6.70% and its EPS growth for past 5 years was 43.40%. IRIDEX Corporation (NASDAQ:IRIX) monthly performance is -0.19%.On March 30, IRIDEX Corporation (NASDAQ:IRIX) announced that the United States Patent and Trademark Office granted the Company a patent for a new proprietary disposable device intended to replace certain suturing techniques in eye surgery. The iClip Closure Device will initially be focused on trabeculectomies and is intended to expand to a broader range of ophthalmic surgical procedures in the future